Enzalutamide in Metastatic Prostate Cancer before ChemotherapyTomasz M. Beer, Bertrand Tombal, Ian D. Davis et al.|New England Journal of Medicine|2014Cited by 3k
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL StudyTomasz M. Beer, Bertrand Tombal, Andrew J. Armstrong et al.|European Urology|2016Cited by 414
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelHao G. Nguyen, Christopher P. Evans|Oncogene|2014Cited by 210
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Ken Herrmann, Alberto Bossi et al.|European Journal of Cancer|2023Cited by 156
Identification of a bladder cancer-specific ligand using a combinatorial chemistry approachHongyong Zhang, Chong-xian Pan, Olulanu H. Aina et al.|Urologic Oncology Seminars and Original Investigations|2010Cited by 53